Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1927 1
1931 2
1934 1
1935 2
1936 2
1938 1
1939 3
1940 8
1941 7
1942 7
1943 8
1945 11
1946 15
1947 16
1948 19
1949 6
1950 23
1951 23
1952 43
1953 37
1954 41
1955 31
1956 35
1957 28
1958 29
1959 44
1960 29
1961 32
1962 55
1963 100
1964 208
1965 161
1966 182
1967 274
1968 360
1969 432
1970 442
1971 537
1972 620
1973 681
1974 753
1975 922
1976 1076
1977 1074
1978 1093
1979 1231
1980 1211
1981 1193
1982 1389
1983 1408
1984 1498
1985 1503
1986 1571
1987 1716
1988 1748
1989 1742
1990 1747
1991 1807
1992 1777
1993 1700
1994 1668
1995 1611
1996 1510
1997 1536
1998 1571
1999 1540
2000 1688
2001 1755
2002 1760
2003 1675
2004 1744
2005 1778
2006 1871
2007 1912
2008 2034
2009 2018
2010 2167
2011 2388
2012 2523
2013 2444
2014 2479
2015 2520
2016 2246
2017 2239
2018 2083
2019 2101
2020 3085
2021 3081
2022 2545
2023 2340
2024 872

Text availability

Article attribute

Article type

Publication date

Search Results

89,955 results

Results by year

Filters applied: . Clear all
Page 1
Enalaprilat.
Marte F, Dersnah GD, Cassagnol M. Marte F, et al. 2023 Apr 24. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2024 Jan–. 2023 Apr 24. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2024 Jan–. PMID: 30485004 Free Books & Documents.
Enalaprilat is the active metabolite of the oral prodrug enalapril maleate. Enalaprilat is poorly absorbed orally and requires intravenous administration. ...
Enalaprilat is the active metabolite of the oral prodrug enalapril maleate. Enalaprilat is poorly absorbed orally and r …
Thrombotic microangiopathy in aHUS and beyond: clinical clues from complement genetics.
Fakhouri F, Frémeaux-Bacchi V. Fakhouri F, et al. Nat Rev Nephrol. 2021 Aug;17(8):543-553. doi: 10.1038/s41581-021-00424-4. Epub 2021 May 5. Nat Rev Nephrol. 2021. PMID: 33953366 Review.
The potential relevance of complement genetics for distinguishing the underlying mechanisms of malignant hypertension-associated TMA should be assessed with caution owing to the overlap between aHUS and other causes of malignant hypertension. ...
The potential relevance of complement genetics for distinguishing the underlying mechanisms of malignant hypertension-associat …
A case of malignant hypertension as a presentation of atypical hemolytic uremic syndrome.
Omiya C, Koga K, Nishioka K, Sugawara A, Sugawara Y, Yoshida Y, Ikeda Y, Yahata K. Omiya C, et al. Clin Nephrol Case Stud. 2023 Apr 28;11:72-78. doi: 10.5414/CNCS110901. eCollection 2023. Clin Nephrol Case Stud. 2023. PMID: 37143613 Free PMC article.
INTRODUCTION: Malignant hypertension (mHTN) damages multiple target organs, including the kidneys. mHTN has been regarded as one of the causes of secondary thrombotic microangiopathy (TMA); however, a high prevalence of complement gene abnormalities was recently rep …
INTRODUCTION: Malignant hypertension (mHTN) damages multiple target organs, including the kidneys. mHTN has been regarded as o …
Clinical characteristics and outcomes of a patient population with atypical hemolytic uremic syndrome and malignant hypertension: analysis from the Global aHUS registry.
Halimi JM, Al-Dakkak I, Anokhina K, Ardissino G, Licht C, Lim WH, Massart A, Schaefer F, Walle JV, Rondeau E. Halimi JM, et al. J Nephrol. 2023 Apr;36(3):817-828. doi: 10.1007/s40620-022-01465-z. Epub 2022 Sep 24. J Nephrol. 2023. PMID: 36152218 Free PMC article.
INTRODUCTION: Atypical hemolytic uremic syndrome (aHUS) is a rare form of thrombotic microangiopathy (TMA) often caused by alternative complement dysregulation. ...TRIAL REGISTRATION DETAILS: Atypical Hemolytic-Uremic Syndrome (aHUS) Regi …
INTRODUCTION: Atypical hemolytic uremic syndrome (aHUS) is a rare form of thrombotic microangiopathy (TMA) often caused …
Severe and malignant hypertension are common in primary atypical hemolytic uremic syndrome.
Cavero T, Arjona E, Soto K, Caravaca-Fontán F, Rabasco C, Bravo L, de la Cerda F, Martín N, Blasco M, Ávila A, Huerta A, Cabello V, Jarque A, Alcázar C, Fulladosa X, Carbayo J, Anaya S, Cobelo C, Ramos N, Iglesias E, Baltar J, Martínez-Gallardo R, Pérez L, Morales E, González R, Macía M, Draibe J, Pallardó L, Quintana LF, Espinosa M, Barros X, Pereira F, Cao M, Moreno JA, Rodríguez de Córdoba S, Praga M; Spanish Group for the Study of Glomerular Diseases (GLOSEN). Cavero T, et al. Kidney Int. 2019 Oct;96(4):995-1004. doi: 10.1016/j.kint.2019.05.014. Epub 2019 May 31. Kidney Int. 2019. PMID: 31420192 Free article.
A cohort of 110 patients with malignant hypertension caused by diseases other than aHUS served as control. Thirty-six patients with aHUS presented Grade 2 or Grade 3 hypertension and funduscopic examination showed malignant hypertension in 19. Genetic …
A cohort of 110 patients with malignant hypertension caused by diseases other than aHUS served as control. Thirty-six patients …
Pharmacology of enalapril in children: a review.
Smeets NJL, Schreuder MF, Dalinghaus M, Male C, Lagler FB, Walsh J, Laer S, de Wildt SN. Smeets NJL, et al. Drug Discov Today. 2020 Aug 21:S1359-6446(20)30336-6. doi: 10.1016/j.drudis.2020.08.005. Online ahead of print. Drug Discov Today. 2020. PMID: 32835726 Free article. Review.
Enalapril is an angiotensin-converting enzyme (ACE) inhibitor that is used for the treatment of (paediatric) hypertension, heart failure and chronic kidney diseases. Because its disposition, efficacy and safety differs across the paediatric continuum, data from adults cann …
Enalapril is an angiotensin-converting enzyme (ACE) inhibitor that is used for the treatment of (paediatric) hypertension, heart fail …
Targeting renin-angiotensin system in malignant hypertension in atypical hemolytic uremic syndrome.
Raghunathan V, Sethi SK, Dragon-Durey MA, Dhaliwal M, Raina R, Jha P, Bansal SB, Kher V. Raghunathan V, et al. Indian J Nephrol. 2017 Mar-Apr;27(2):136-140. doi: 10.4103/0971-4065.181462. Indian J Nephrol. 2017. PMID: 28356668 Free PMC article.
Hypertension is common in hemolytic uremic syndrome (HUS) and often difficult to control. Local renin-angiotensin activation is believed to be an important part of thrombotic microangiopathy, leading to a vicious cycle of progressive renal injury and i …
Hypertension is common in hemolytic uremic syndrome (HUS) and often difficult to control. Local renin-angiotensi …
Hemolytic-uremic syndrome, malignant hypertension and IgA nephropathy: successful treatment with plasma exchange therapy.
Pipili C, Pantelias K, Papaioannou N, Paraskevakou H, Grapsa E. Pipili C, et al. Transfus Apher Sci. 2012 Oct;47(2):155-8. doi: 10.1016/j.transci.2012.06.018. Epub 2012 Aug 11. Transfus Apher Sci. 2012. PMID: 22892290 Review.
A young patient with hemolytic-uremic syndrome and malignant hypertension with serious deterioration of renal function is described whose biopsy specimen showed additional IgA mesangial deposits. ...In the following years, he achieved clinical r …
A young patient with hemolytic-uremic syndrome and malignant hypertension with serious deterioration of r …
Catastrophic APS in the context of other thrombotic microangiopathies.
Rodríguez-Pintó I, Espinosa G, Cervera R. Rodríguez-Pintó I, et al. Curr Rheumatol Rep. 2015 Jan;17(1):482. doi: 10.1007/s11926-014-0482-z. Curr Rheumatol Rep. 2015. PMID: 25604575 Review.
Thus, the differential diagnosis of CAPS includes thrombotic thrombocytopenic purpura (TTP), typical and atypical hemolytic uremic syndrome (HUS), systemic infections, malignancies, pregnancy-related disorders, malignant hypertension, heparin-in …
Thus, the differential diagnosis of CAPS includes thrombotic thrombocytopenic purpura (TTP), typical and atypical hemolytic uremic …
89,955 results
You have reached the last available page of results. Please see the User Guide for more information.